[Retracted] HPV-16 Expression and Loss of Cell Differentiation in Primary Bladder Tumors

Figure 5

Analysis of patient prognosis. Note: the proportions of patients with single tumor and multiple tumors were 19.30% and 80.70%, respectively, and the tumor-free survival, recurrence, and mortality of patients were 64.91%, 29.82%, and 5.26%, respectively.